Gladstone Investment (NASDAQ:GAIN) reported quarterly earnings of $0.26 per share which met the analyst consensus estimate. This is unchanged from the same period last year.
10x Genomics Surpasses 100 Xenium Analyzer Shipments In The 8-Months Since Launch
Rapid growth and adoption of Xenium Analyzer demonstrates strength of company's innovation engine, broad commercial reach and operational scale